Management [ocac]
Patients [podg]
Atrial Fibrillation [patf]
dronedarone [orch, phsu]
Place [spco]
therapy [ftcn]
Pharmacologic Management [hlca]
Atrial Fibrillation [patf]
Includes [ftcn]
Rhythm [fndg]
strategies [menp]
Anti-arrhythmic Agent [phsu]
EG [geoa]
Amiodarone [orch, phsu]
Flecainide [orch, phsu]
Propafenone [orch, phsu]
Limited [ftcn]
Serious [qlco]
toxicities [inpo]
Including [ftcn]
effects [qlco]
pulmonary toxicity [patf]
???lead [elii, hops]
Reduced [qlco]
Reticular [spco]
Efficacy [qlco]
Rhythm [fndg]
strategies [menp]
dronedarone [orch, phsu]
Anti-arrhythmic Agent [phsu]
effective [qlco]
Maintenance [acty]
Sinus rhythm [fndg]
dronedarone [orch, phsu]
ventricular [bpoc]
Hospitalization [hlca]
cardiovascular events [fndg]
dronedarone [orch, phsu]
Recommended [idcn]
American Heart Association [hcro]
College [mnob]
Cardiology [bmod]
Foundation [orgt]
Rhythm [fndg]
society [orgt]
Guidelines [inpr]
Update [tmco]
Management [ocac]
Atrial Fibrillation [patf]
Patients [podg]
Minimal [qlco]
Heart disease [dsyn]
coronary artery disease [dsyn]
Hypertension [dsyn]
Left Ventricular Hypertrophy [dsyn]
dronedarone [orch, phsu]
Contraindicated [fndg]
Patients [podg]
New York Heart Association Class IV [fndg]
Failure [ftcn]
New York Heart Association Class II [fndg]
III [inpr]
Failure [ftcn]
Decompensation [fndg]
Hospitalization [hlca]
Referral [hlca]
specialized [qlco]
Heart failure [dsyn]
Clinic [hcro, mnob]
